Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Why FRP shares are up 34% since we said to buy

AJ Bell is an easy to use, award-winning platform Open an account
We've accounts to suit every investing need, and free guides and special offers to help you get the most from them.
You can get a few handy suggestions, or even get our experts to do the hard work for you – by picking one of our simple investment ideas.
All the resources you need to choose your shares, from market data to the latest investment news and analysis.
Funds offer an easier way to build your portfolio – we’ve got everything you need to choose the right one.
Starting to save for a pension, approaching retirement, or after an explainer on pension jargon? We can help.
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
FRP Advisory (FRP:AIM) 164p
Gain to date: 34%
We originally recommended buying advisory group FRP at 122p on 16 September 2021 because we believed it would benefit from an increase in insolvencies as the Government ended pandemic-linked insolvency restrictions.
The company specialises in corporate restructuring and helps businesses navigate the process of going into administration or liquidation.
What’s happened since we said to buy?
The subsequent advance in the share price has been driven by a rise in the number of insolvencies and administrations since the start of 2022.
According to data from the Insolvency Service, total company insolvencies increased from 1,567 in January to 1,827 in July, with the majority of these being creditors’ voluntary liquidations. These have increased from 1,359 in January to 1,609 in July.
The number of County Court judgments filed by creditors trying to recover debts has also been on an increasing trend. This rebound has been boosted by a clearing of the Covid-induced backlog. The corporate finance division has also driven growth as FRP has benefited from the Spectrum and JDC Group acquisitions.
The former, acquired for £9.4 million, extended the group’s geographical footprint in London and the south. The latter acquired for £5.3 million provided FRP with a presence in the east of England and bolstered its forensic accounting footprint.
What should investors do next?
We recommend taking profits given the 34% share price increase coupled with the substantial re-rating in the earnings multiple.
In mid-September 2021, when we initially recommended buying FRP, it was trading on a calendar 2022 price to earnings ratio of 15.9. This now stands at 21.4-times.
The shares are no longer attractive from a valuation perspective given that management left earnings guidance unchanged at the full year results in July. Broker Liberum forecasts pre-tax profit and earnings per share growth for the current financial year (to 30 April 2023) of 5.6% and 3.9% respectively.
For the following year profit is expected to rise by 6.5% but earnings per share growth is forecast to be flat.
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
The value of your investments can go down as well as up and you may get back less than you originally invested. We don't offer advice, so it's important you understand the risks, if you're unsure please consult a suitably qualified financial adviser. Tax treatment depends on your individual circumstances and rules may change. Past performance is not a guide to future performance and some investments need to be held for the long term.